WIN-Partners Co., Ltd.
3183.TJPXHealthcareMedical - Distribution
Latest quote
¥1,292
+¥3.00 · +0.23%
3183.T company overview
Regular session · JST · Market data may be delayed.
Company profile
Company websiteEstablished in 1973 and headquartered in Tokyo, Japan, WIN-Partners Co., Ltd. leverages its subsidiaries to distribute a comprehensive range of medical devices to healthcare institutions, primarily across Japan. Its diverse product offerings include cutting-edge cardiovascular tools such as percutaneous transluminal coronary angioplasty balloon catheters, drug-eluting stents, and intravascular ultrasound catheters. The company also supplies devices for cardiac rhythm management, like pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters. Furthermore, WIN-Partners provides structural and peripheral vascular products, including stent grafts, transcatheter heart valves, mechanical heart valves, and various stents and embolic coils. Rounding out its portfolio are diabetes management systems such as insulin pumps and continuous glucose monitoring devices, in addition to magnetic resonance imaging equipment.
- Industry
- Medical - Distribution
- Sector
- Healthcare
- Headquarters
- JP
- CEO
- Hideumi Akizawa
- Listed since
- Sep 16, 2002
- Employees
- 653
Market position
Day range
Current ¥1,292
52-week range
Current ¥1,292
- Open
- ¥1,289
- Previous close
- ¥1,289
- Volume
- 6.1K
- 0.35× average
- Average volume
- 17.29K
- Average daily volume
- Market cap
- 35.53B JPY
- Beta
- 0.18
- Market reference 1
- 50-day average
- ¥1,272.82
- +1.51% above average
- 200-day average
- ¥1,311.7
- -1.50% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 22.95B JPY
- P/E (TTM)
- 17.54×
- P/B (TTM)
- 1.6×
- P/S (TTM)
- 0.39×
- EV / EBITDA
- 6.91×
- Earnings yield
- 5.55%
- Free cash flow yield
- 7.08%
- Dividend yield
- 4.18%
Profitability & efficiency
- Gross margin
- 11.63%
- Operating margin
- 3.16%
- Net margin
- 2.21%
- Return on equity
- 9.10%
- Return on assets
- 4.18%
- Return on invested capital
- 8.17%
Financial health
- Debt / equity
- 0.04×
- Current ratio
- 1.7×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (JPY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 90.39B JPY | 81.41B JPY | 77.06B JPY | 70.85B JPY | 66.39B JPY |
| Cost of goods sold | 79.73B JPY | 71.52B JPY | 67.53B JPY | 62.19B JPY | 57.87B JPY |
| Gross profit | 10.66B JPY | 9.89B JPY | 9.53B JPY | 8.66B JPY | 8.52B JPY |
| Selling, general, and administrative | 7.64B JPY | 7.09B JPY | 6.91B JPY | 6.19B JPY | 5.76B JPY |
| Operating expenses | 7.64B JPY | 7.09B JPY | 6.91B JPY | 6.19B JPY | 5.76B JPY |
| Interest income | 54.87M JPY | 17.28M JPY | 988K JPY | 111K JPY | 133K JPY |
| Interest expense | — | — | 12K JPY | 64K JPY | — |
| Depreciation and amortization | 300.08M JPY | 231.66M JPY | 195.62M JPY | 166.2M JPY | 160.52M JPY |
| Operating income | 3.02B JPY | 2.81B JPY | 2.63B JPY | 2.47B JPY | 2.76B JPY |
| Net income | 2.12B JPY | 2.02B JPY | 1.84B JPY | 2.05B JPY | 1.83B JPY |
Company facts updated Aug 24, 2026.
Earnings
- Latest EPS result
- 14.64
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Corporate actions
Corporate action history
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Dec 28, 2016 | 2:1 | — | — |
Stock split | Jun 25, 2009 | 100:1 | — | — |
Stock split | Mar 28, 2005 | 5:1 | — | — |
Stock split | Mar 26, 2003 | 5:1 | — | — |
Effective Dec 28, 2016
2:1
Effective Jun 25, 2009
100:1
Effective Mar 28, 2005
5:1
Effective Mar 26, 2003
5:1
3183.T peers
ETFs holding 3183.T
Funds reporting this stock among their holdings, ordered by reported position size.
Continue in GoAI
Research 3183.Tresearch.disclaimer